Kalamazoo, MI, United States of America

Joseph J Ursprung


Average Co-Inventor Count = 1.3

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1976-1978

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Joseph J Ursprung: Innovator in Hypotensive Agents

Introduction

Joseph J Ursprung is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of hypotensive agents. With a total of 5 patents to his name, Ursprung's work has had a meaningful impact on medical science.

Latest Patents

Ursprung's latest patents include innovative compounds such as pyridine containing morpholines. These new 4-amino-2-lower-alkyl-6-variable-pyridine-1-oxides are described in detail, showcasing a new process for their synthesis. The 6-variable components include lower-alkyl, amino, or substituted amino groups, which may consist of saturated heterocyclic amino structures like pyrrolidinyl and piperidino. These compounds serve as hypotensive agents, effectively reducing blood pressure in animal models. Another significant patent involves pyridine n-oxides, which shares similar characteristics and applications as the previously mentioned compounds.

Career Highlights

Ursprung has been associated with The Upjohn Company, where he has utilized his expertise to advance pharmaceutical research and development. His work has contributed to the creation of effective treatments for hypertension, showcasing his commitment to improving health outcomes.

Collaborations

Throughout his career, Ursprung has collaborated with esteemed colleagues such as John M McCall and Sylvester D Folz. These partnerships have fostered innovation and have been instrumental in the successful development of his patented compounds.

Conclusion

Joseph J Ursprung stands out as a dedicated inventor whose work in hypotensive agents has made a significant impact in the pharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…